BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10905631)

  • 1. Retinal structure and function in an animal model that replicates the biochemical hallmarks of desmosterolosis.
    Fliesler SJ; Richards MJ; Miller C; Peachey NS; Cenedella RJ
    Neurochem Res; 2000 May; 25(5):685-94. PubMed ID: 10905631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol synthesis in the vertebrate retina: effects of U18666A on rat retinal structure, photoreceptor membrane assembly, and sterol metabolism and composition.
    Fliesler SJ; Richards MJ; Miller CY; Cenedella RJ
    Lipids; 2000 Mar; 35(3):289-96. PubMed ID: 10783006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Source of cholesterol for the ocular lens, studied with U18666A: a cataract-producing inhibitor of lipid metabolism.
    Cenedella RJ
    Exp Eye Res; 1983 Jul; 37(1):33-43. PubMed ID: 6873203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmosterolosis presenting with multiple congenital anomalies and profound developmental delay.
    Andersson HC; Kratz L; Kelley R
    Am J Med Genet; 2002 Dec; 113(4):315-9. PubMed ID: 12457401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmosterolosis and desmosterol homeostasis in the developing mouse brain.
    Allen LB; Genaro-Mattos TC; Porter NA; Mirnics K; Korade Z
    J Inherit Metab Dis; 2019 Sep; 42(5):934-943. PubMed ID: 30891795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked alteration of sterol metabolism and composition without compromising retinal development or function.
    Fliesler SJ; Richards MJ; Miller C; Peachey NS
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1792-801. PubMed ID: 10393050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis.
    Waterham HR; Koster J; Romeijn GJ; Hennekam RC; Vreken P; Andersson HC; FitzPatrick DR; Kelley RI; Wanders RJ
    Am J Hum Genet; 2001 Oct; 69(4):685-94. PubMed ID: 11519011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical phenotype of desmosterolosis.
    FitzPatrick DR; Keeling JW; Evans MJ; Kan AE; Bell JE; Porteous ME; Mills K; Winter RM; Clayton PT
    Am J Med Genet; 1998 Jan; 75(2):145-52. PubMed ID: 9450875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of chronic epileptiform activity in the rat by an inhibitor of cholesterol synthesis, U18666A.
    Bierkamper GG; Cenedella RJ
    Brain Res; 1978 Jul; 150(2):343-51. PubMed ID: 678974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: electrophysiologic, biochemical, and morphologic features.
    Fliesler SJ; Peachey NS; Richards MJ; Nagel BA; Vaughan DK
    Arch Ophthalmol; 2004 Aug; 122(8):1190-200. PubMed ID: 15302661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmosterol and DHCR24: unexpected new directions for a terminal step in cholesterol synthesis.
    Zerenturk EJ; Sharpe LJ; Ikonen E; Brown AJ
    Prog Lipid Res; 2013 Oct; 52(4):666-80. PubMed ID: 24095826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of cataract production by 3-beta(2-diethylaminoethoxy) androst-5-en-17-one hydrochloride, U18666A: an inhibitor of cholesterol biosynthesis.
    Cenedella RJ; Bierkamper GG
    Exp Eye Res; 1979 Jun; 28(6):673-88. PubMed ID: 467524
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholesterol and lipid peroxidation in 3 beta-(2-diethylaminoethoxy)- androst-5-en-17-oneHCl (U18666A) induced cataractogenesis in rats.
    Yadav S; Rawal UM
    Indian J Exp Biol; 1992 Feb; 30(2):147-8. PubMed ID: 1521865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes.
    Cenedella RJ
    Lipids; 2009 Jun; 44(6):477-87. PubMed ID: 19440746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First case of desmosterolosis diagnosed by prenatal whole exome sequencing.
    Hill C; Noureldein M; Karkhanis P; Kinning E; Vijay S; Gowda H
    Am J Med Genet A; 2023 Mar; 191(3):859-863. PubMed ID: 36538928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmosterolosis presenting with multiple congenital anomalies.
    Rohanizadegan M; Sacharow S
    Eur J Med Genet; 2018 Mar; 61(3):152-156. PubMed ID: 29175559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and validation of a conditional knockout mouse model for desmosterolosis.
    Kanuri B; Fong V; Ponny SR; Weerasekera R; Pulakanti K; Patel KS; Tyshynsky R; Patel SB
    J Lipid Res; 2021; 62():100028. PubMed ID: 33524375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatoma cell line Hep G2. Effects of inhibitors of cholesterol synthesis on enzyme activity.
    Boogaard A; Griffioen M; Cohen LH
    Biochem J; 1987 Jan; 241(2):345-51. PubMed ID: 3036060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrelationships of ubiquinone and sterol syntheses in cultured cells of neural origin.
    Volpe JJ; Obert KA
    J Neurochem; 1982 Apr; 38(4):931-8. PubMed ID: 7062041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the mechanisms of the epileptiform activity induced by U186661. I Gross alteration of the lipids of synaptosomes and myelin.
    Sarkar CP; Bierkamper GG; Cenedella RJ
    Epilepsia; 1982 Jun; 23(3):243-55. PubMed ID: 7084136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.